Informed prostate cancer risk-adjusted testing: a new paradigm

Phillip D Stricker, Mark Frydenberg, Andrew Kneebone

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


* Currently there is significant confusion and polarisation about prostate cancer screening for both patients and physicians alike. * We propose a risk-adjusted testing programme, which would lead to fewer patients who need to be tested and treated to save a life and also eliminate inappropriate prostate-specific antigen testing in the elderly and patients with severe co-morbidities where there is no clear benefit.
Original languageEnglish
Pages (from-to)30 - 34
Number of pages5
JournalBJU International
Issue numberSuppl S4
Publication statusPublished - 2012

Cite this